No Detail Found!

Non-steroidal-anti-inflammatory-drugs induced gastrotoxicity

Author(s)
Javed IqbalFarooqaI Department of Medicine & Gastroenterology, Saidu Medical College, Sawat, Pakistan.
Rukhsana Javed Farooqi Khyber Teaching Hospital, Peshawar, Pakistan.
Abstract
Non-Steroidal-Anti-Inflammatory-Drugs (NSAIDs) toxicity in the upper gastrointestinal tract is amongst the most common serious drug-induced toxicity. Enormous progress has been made in the understanding of NSAIDs-induced peptic? ulcer disease in the last decade. Inhibitors in at-risk patients would require further investigation. The introduction of Cox-Il specific agents offers the opportunity for safe and effective treatment for patients who are at high risk for developing GI complications. However, large, long-term, randomized and controlled studies are needed in the future to assess the overall safety of Cox-Il specific inhibitors, especially in organs outside the GI tract. Whilst several matters of detail about use of Cox-Il specific inhibitors persist, there is sufficient data to be confident that Cox-Il specific inhibitors represent a therapeutic revolution capable of reducing NSAIDs associated gastric complications substantially. Whether such complications will be at placebo levels will require further study. The available data is still limited, particularly in the at-risk groups i.e., elderly, patients with previous history of GI complications, and are on corticosteroids.
Publication Details
Page(s) 650-655
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 10, Year: 2001

Request the full text from PASTIC

Keywords
gastrointestinal diseases, Non-Steroidal, Anti-Inflammatory Agents
References
Koff RS . .. , : 2080-5.
Hawkey CJ .1990 .. NSAIDs and peptic ulcersB.r Med J ing withenteric-coatoerdbufferedproducLta.ncet, 300 : 1413-6.
. .Associatioonf ciatedgastropathiny:cidenceand riskfactormsodel. UGI toxicityof NSAIDs with continuedexposure. Z77yW1999;, 315 : 133-7.
> . .EvidenceforweakNSAIDs use and increasedriskforpepticulcerdis­ ening of gastricmucus integrityby Campylobacter easein elderlpyersonsA. , : 585-90.
.1992 .Pylorin patientsreceiving NSAIDs - correlatwiointhpepticulceratioJnd. inPathol, 45 : 135-9.
.1991 .Catalan countriesstudy on UGI bleeding:UGI bleedingin relatiotnoprevioususe of analgesicsand NSAIDs. Lancet, 337 : 85-9.
. .Pyloraind smokingon gastricmucosal adaptatiotnoNSAIDs. AlimentPharmacolTher, 997 : 907-12.
Taha AS .1988 .. MedJ, 297 : 1017-21.
---- SorensenMM ,---- H.,Pyloroin H. .1995 .a controlldeoduble-blintdrialA. limentPharmacol Ther, 9 : 127-35.
Taha AS .1995 .SturrocRkD, RusselRll.Mucosalerosionsin long-termNSAIDs users:predispositiotnoulceration and relatiotnoH. , : 334-6.
Gueguen A,NakacheJ. A . .Ankylosing spondylitisw: hatis theoptimumduratioonfa clinical study? A one yearversusa 6 weeksNSAIDs trial. , : .
.1998 .Omeprazolceomparedwith ranitidinefor ulcersassociatedwith NSAIDs. NEngJMed, 338 : 719-26.
Chan FKL,Sung JY,Chung SC .1997 .Randomisedtrialof eradicatioonfH. , : 975-9.
.1995 .. comparisoonfthreeregimens.Ann Intern Med, 123 : 344-50.
.1993 .Duodenaland gas trieulcerspreventionwith misoprostoinl arthriti patienttsakingNSAIDs. AnnlnternMed, 119 : 257-62.
. .Misoprostocoladministrewdithdiclofenafcorprevention of gastroduodenaullcers:a one-yearstudy. DigDisSciV#&\, 40 : 1125-31.
.1998 .. AlimentPharmacolTher, 12 : 135-40.
Fu JY,NeedlemanP. JY .1998 .The maintenancaecidsuppressiotnopreventrecurreunltcer 2 hemorrhagien high-riskNSAID. users:a prospective randomizedstudy. Gastroenterol, 114 : A87-9.
Hawkey CJ .1993 .Pyloreiradicatioin patientson thaseisoenzymeselectivityt:hepotentiaflorsafer NSAID: helpNSAIDs study. , 95 : 40S-46S.
Chan FKL,Sung JY,Suen R .1999 .PyloriimpairhealingofNSAIDs associatebdleeding bitionin rheumatoiadrthritJisR. InterpretintgheclinicaslignifPharmacolTher, 39 : 189-97.
.1991 .PatrignanP,i PanaraMR, GrecoA. Ranitidinein the treatmeontfNSAIDs associategdastriacnd duodenal 59, : 252-6.
HawakeyCJ. .1989 .naseactivityof human bloodprostaglandeinndoperEffectof omeprazolaend ranitidine^on ulcerhealing • oxidesynthasesJ. PharmacolExp Therap, 320 : 69-75.
Rheumatology .1999 .. , 38 : 235-44.
.1999 .Incidenceof upper gastrointestinpaelrforations,ymptomatic ulcerasnd bleeding. RofecoxibcomparetdoNSAIDs, 282 : 1929-33.
Lanza F,Simon T,Quan H .1997 .Selectiveinhibitionof cyclooxygena$ew-2ithMK-0966 (250 MG QD. isass ociatedwithlessgastroduodendaalmagethanaspirin 650 MG Q.I.D.oribuprofen800 MG T.I.D. (Abstract) Gastroenterology, 112 : A194.
Hawkey CJ .1999 .HarperS. Effectof Cox-Ilinhibitor rofecoxibon ulcerformation:a double-blind comparisonwith ibuprofenand placebo(Abstract). Gastroenterology, 116 : A229.
. .cerasnd bleed sin patientstreatewdithrofecoxibvs nonspecificcycl­o oxygenaseinhibitorsG. astroenterology\999'AA^\\99Z-9., : .
Mengle-GawL .1997 .plateletffectsof SC-58635, a novelCox-llselective 45(SupplV. rthritisRheum, 40(Suppl) : S93-8.
Hawkey CJ,MorrisoBnW. CJ .2000 .Effectsofspecific effectof rofecoxibib,uprofeno,rplacebon thegas­ inhibitionof cyclooxygenase-o2n sodium balance, troduodenamlucosa of osteoarthritAirsth.ritis Rheum hemodynamicsandvasoactiveeicosanoiddsJ. , 999 : 735-41.
0

Citations

0

Downloads

44

Views